Market Tracker

12/19 11:01pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

9.65
Data as of Dec 19
 -0.04 / -0.41%
Today’s Change
2.05
Today|||52-Week Range
11.68
+282.94%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close9.69
Today’s open9.67
Day’s range9.36 - 9.74
Volume1,380,236
Average volume (3 months)572,546
Market cap$369.5M
Dividend yield--
Data as of 4:00pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)-31.43%
Earnings growth (next 5 years)-5.90%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book3.24

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...+0.05+0.88%
SUPNSupernus Pharmaceuti...-0.03-0.34%
IDRAIdera Pharmaceutical...-0.05-1.20%
VTAEVitae Pharmaceutical...-0.16-0.71%
Data as of 4:00pm ET, 12/19/2014

Financials

Next reporting dateMarch 16, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts